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Background: Besides smoking, low or high body mass index (BMI) is associated with 
chronic lung disease (CLD). It is unclear how CLD is associated with BMI, whether smoking 
interacts with this association, and how the associations differ from the patterns known for 
lung cancer.
Population and Methods: Our population comprised 35,212 individuals aged 14–99, who 
participated in population-based surveys conducted in 1977–1993 in Switzerland (mortality 
follow-up until 2014). We categorized smokers into never, former, light, and heavy; and BMI 
into underweight, normal weight, overweight, and obese. Hazard ratios (HRs) were obtained 
with multivariable Cox proportional hazards models.
Results: CLD mortality was strongly associated with being underweight. This was mainly 
due to the effect in men (HR 5.04 [2.63–9.66]) and also prevailed in never smokers (HR 1.81 
[1.11–3.00]). Obesity was also associated with CLD mortality (HR men: 1.37 [1.01–1.86], 
women: 1.39 [0.90–2.17]), but not with lung cancer mortality. In line with lung cancer, for CLD, 
the BMI–mortality association followed the same shape in all smoking categories, suggesting 
that this association was largely independent of smoking status.
Conclusion: The shape of the BMI–mortality association was inversely linear for lung cancer 
but followed a U-shape for CLD. Further research should examine the potentially protective 
effect of obesity on lung cancer occurrence and the possibly hazardous impact of underweight 
on CLD development.
Keywords: chronic lung disease, lung cancer, mortality, body mass index, underweight, 
obesity, smoking
Introduction
Worldwide, COPD was the third and lung cancer the fifth most common cause 
of death in 2010.1 While smoking clearly increases the risk of both diseases,1 the 
impact of body mass index (BMI) is unclear. For both diseases, higher BMI could 
be a protective rather than a risk factor, but results are conflicting.2–10 In under-
weight individuals, the association between low BMI and disease outcome may be 
confounded by smoking, because smoking may be more prevalent in underweight 
than in normal weight people.7,8,11,12 Moreover, reversed causation may bias the 
BMI–disease association, because COPD and lung cancer can lead to weight loss.8 
Therefore, smoking and BMI need to be jointly analyzed. In a general population 
sample from Switzerland, we aim to elaborate similarities and differences regard-
ing associations of BMI and smoking with mortality from chronic lung disease 
(CLD = mainly COPD) and lung cancer.
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Materials and methods
study population
The study population consists of originally 35,914 
individuals aged 14–99 years at baseline who participated 
in one of four different population-based studies conducted 
between 1977 and 1993: NRP 1A (National Research 
Program 1A, 1977–1979, n=8,008); SOMIPOPS (SOcio-
Medical Indicators for the POPulation of Switzerland, 
1982, n=4,104); Swiss MONICA (MONItoring of trends 
and determinants in CArdiovascular disease, three waves: 
I, 1984–1986; II, 1988/1989; III, 1992/1993, n=9,940); and 
the first SHS (Swiss Health Survey, 1992/1993, n=13,862), 
for details, see the study by Roh et al.13 The studies were 
conducted according to the ethical guidelines of the Swiss 
Academy of Medical Sciences. Informed consent was only 
obtained for SHS 92/93. For the other studies, the use of 
written informed consent was not custom when they were 
conducted, and the ethics committee (Cantonal Ethics Com-
mittee of the Canton of Zurich, KEK-ZH) approved our study 
under these conditions. For details, see the study by Roh 
et al.13 Mortality follow-up until 2014 was obtained through 
anonymous record linkage with the Swiss National Cohort.13 
After exclusion of 30 deceased foreign nationals with miss-
ing cause of death, 612 subjects who died of external causes, 
1 subject with invalid entry date, and 59 subjects with miss-
ing smoking status, our study population comprised 35,212 
participants with a median follow-up time of 22.3 years and 
a maximum of 37.9 years.
Body mass index
BMI was defined as weight (kg) divided by the square 
of height (m2). Subjects were classified: normal weight 
(18.5# BMI ,25.0 kg/m2), underweight (BMI ,18.5 
kg/m2), overweight (25.0# BMI ,30.0 kg/m2), and obese 
(BMI $30.0 kg/m2).
smoking
Only baseline information was available for smoking status. 
Smoking was categorized: never, former (reported having 
ever smoked for .6 months), current light (,20 cigarettes 
a day), and current heavy ($20).
Covariates
In the final model, we adjusted for age (years), sex, survey 
(NRP 1A, SOMIPOPS, MONICA I–III, SHS), years of 
education (number of years: 0–30), marital status (single, 
married, widowed, divorced), nationality (Swiss vs 
foreign), self-reported physical activity (four categories: 
daily, several times per week, once per week, and less), 
alcohol consumption (consumption the day before the inter-
view: yes vs no), and a diet proxy (“regularly eating three 
main meals per day” and “eating fruits and vegetables at 
least once per day”: yes or no). For all covariates, we used 
baseline information.
end points
In view of frequent misclassification14 and in order to capture 
all cases potentially related with harmful exposure/behavior, 
we merged COPD with additional respiratory causes of death 
into a broader category CLD. As a majority of CLD registra-
tions in Swiss cause of death statistics concerns concomitant 
causes of death, we included all mentions of CLD. Of these 
612 CLD deaths, CLD was mentioned as primary cause of 
death in 276 death certificates and in 336 as secondary (con-
comitant) cause. In the latter cases, cardiovascular diseases 
(55%) were the most frequent primary causes mentioned, 
followed by cancer (23%). Lung cancer was rarely mentioned 
as secondary cause of death (1 out of 276 deaths due to 
CLD), and the definition was, therefore, limited to primary 
cause of death. Deaths with lung cancer as primary cause and 
CLD as concomitant were classified as lung cancer. Deaths 
were coded according to the International Classification of 
Diseases (ICD-8 until the end of 1994, ICD-10 thereafter). 
CLD was defined as ICD-8 490–493, 502, 503, 506, 517; 
ICD-10 J40–J47, J68, J96.1, lung cancer as ICD-8 162; 
ICD-10 C33–C34.
statistical analysis
Death rates were directly age-standardized using the 
World Health Organization World Standard Population 
(2000–2025).15 Testing the proportional hazards assumption, 
hazard ratios (HRs) for death due to CLD or lung cancer 
were calculated using Cox proportional hazards regression, 
where survival times were censored if an individual died 
because of any other cause of death or was lost to follow-up. 
We evaluated competing risks regression models,16 where 
survival times were censored only due to loss of follow-up 
but considered competing if the cause of death was not 
CLD or lung cancer, respectively. The results of the two 
analysis strategies were essentially the same, so we have 
reported only results of the Cox proportional hazards mod-
els, which some authors (eg, Lau et al17) have suggested 
to be better at answering questions regarding etiology. 
Analyses were performed with the R programming language 
(version 3.3.2).
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Results
Baseline characteristics are shown in Table 1. Heavy smokers 
tended to be male and to be younger than subjects in other 
smoking categories. They were also less physically active 
and less likely to have a healthy diet or to be Swiss nationals. 
CLD-related death was lowest among never smokers (1.0%), 
intermediate among former and light smokers (2.3% and 
2.0%), and highest among heavy smokers (3.1%). However, 
4.7% of heavy smokers died due to lung cancer compared 
to about 1.6% of former or light smokers and only 0.6% 
of never smokers. The age-standardized death rates were 
10.18/1,000 person-years for all causes combined, 0.66 for 
CLD, and 0.44 for lung cancer (crude: 11.81, 0.76, and 0.69, 
respectively).
As shown in Figure 1, after full adjustment for covari-
ates, the shape of the association of BMI with CLD and lung 
cancer mortality was strikingly consistent in smoking status 
strata. The combined consideration of BMI and smoking 
categories suggests for lung cancer a quite linear inverse 
association with the lowest risk in the highest BMI category 
(obesity). In contrast, the relationship between BMI and CLD 
was U-shaped with similarly increased risks in the highest 
and the lowest BMI category and the lowest risk in normal 
weight individuals.
Discussion
In line with our results, there is a broad agreement regarding 
the linear inverse association of BMI with lung cancer 
risk. However, it remains unclear whether the relation-
ship is causal or whether the association is due to reversed 
causation.6–9 A study looking at changes in BMI showed 
that only recent (2 years ago) but not earlier (20 years ago) 
underweight was associated with increased lung cancer 
risk and that the strongest predictor for death was a decline 
in BMI.8 In contrast to the BMI–lung cancer association, 
overweight was associated with a lower and obesity with a 
higher risk of CLD. This U-shaped (vs linear for lung cancer) 
relationship was also reported in a meta-analysis including 
more than 10 million individuals.10 This is at odds with other 
studies suggesting a lower or a similar risk of CLD among 
obese compared to normal weight subjects.2–5 Evidence for 
an increased CLD mortality risk associated with underweight 
Table 1 Baseline characteristics of the study population
Characteristic Never Former Light Heavy Total Missingsa
Full datasetb (%) 17,028 (47.4) 6,576 (18.3) 7,127 (19.8) 5,123 (14.3) 35,854 (100)
analyzed observations, n (%) 16,727 (47.5) 6,468 (18.4) 7,015 (19.9) 5,002 (14.2) 35,212 (100) 702
Women, n (%) 11,124 (66.5) 2,377 (36.8) 3,441 (49.0) 1,685 (33.7) 18,627 (52.9) 0
Person-years 382,060 140,390 166,768 112,246 801,464
Years of follow-up, mean ± sD 22.8±9.0 21.7±8.9 23.8±9.3 22.4±9.1 22.8±9.1
age, mean ± sD 47.0±16.6 48.6±14.7 42.2±14.7 41.2±12.2 45.5±15.6 0
BMI, mean ± sD 24.2±4.0 25.0±4.0 23.8±3.7 24.3±3.8 24.3±3.9
BMI categories (%)
,18.5 637 (3.9) 126 (2.0) 300 (4.3) 165 (3.3) 1,228 (3.5) 443
18.5–25 (ref) 9,817 (59.6) 3,290 (51.4) 4,311 (62.0) 2,887 (58.2) 20,305 (58.4)
25–30 4,603 (28.0) 2,355 (36.8) 1,927 (27.7) 1,565 (31.6) 10,450 (30.1)
.30 1,400 (8.5) 630 (9.8) 412 (5.9) 344 (6.9) 2,786 (8.0)
Marital status (%)
Married 10,827 (64.8) 4,909 (75.9) 4,516 (64.4) 3,176 (63.5) 23,428 (66.6) 16
Divorced 809 (4.8) 413 (6.4) 507 (7.2) 549 (11.0) 2,278 (6.5)
single 3,594 (21.5) 807 (12.5) 1,712 (24.4) 1,148 (23.0) 7,261 (20.6)
Widowed 1,490 (8.9) 337 (5.2) 275 (3.9) 127 (2.5) 2,229 (6.3)
Other covariates
alcohol use (%) 9,503 (57.1) 4,823 (74.7) 4,930 (70.5) 3,816 (76.4) 23,072 (65.8) 135
healthy diet (%) 12,185 (74.0) 4,379 (69.0) 4,456 (64.9) 2,405 (48.2) 23,425 (67.5) 535
Years of education, mean ± sD 11.5±3.2 12.3±3.3 12.0±3.1 11.8±3.1 11.8±3.2 584
swiss (%) 14,223 (85.0) 5,418 (83.8) 5,693 (81.2) 3,938 (78.7) 29,272 (83.1) 0
Mortality
all, n (%) 4,524 (27.1) 1,891 (29.2) 1,691 (24.1) 1,359 (27.2) 9,465 (26.9)
ClD, n (%) 164 (1.0) 150 (2.3) 142 (2.0) 156 (3.1) 612 (1.7)
lung cancer, n (%) 95 (0.6) 104 (1.6) 121 (1.7) 236 (4.7) 556 (1.6)
Notes: aThe maximum number of missing values in an analysis was 2,027 (some individuals had missing values for multiple variables). bexcluding 60 study participants with 
missing information on smoking status.
Abbreviations: BMI, body mass index; ClD, chronic lung disease.
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is more consistent2,4,5,10–12,18 and could be observed in people 
with preexisting lung disease as well as in individuals with 
normal lung function at baseline.11,18
For both CLD and lung cancer, the respective associa-
tions between BMI and mortality risk were strikingly similar 
in all considered smoking status groups. This corroborates 
other findings, suggesting that the increased CLD risk in 
underweight individuals is not due to smoking.3,7,8,11 Partially 
at odds was a study with a general population sample from 
Italy, showing that the increased risk of overweight/obesity 
for COPD was quite independent of smoking status, while 
in underweight individuals, there was only an increased risk 
in current and former smokers but not in never smokers.12 
Patients with CLD have an increased energy demand. 
However, this only holds true for the most progressed form 
of the disease, and it is very unlikely that such individu-
als were included in our study. In our population, for both 
outcomes – CLD and lung cancer – underweight and heavy 
smoking combined constituted a high risk of death (HR of 
about 15). Generally, somewhat lower relative risks for this 
combination were reported.8,12
Our study has limitations. The single cross-sectional 
assessment of risk factors (smoking, BMI) at baseline 
precludes conclusions regarding causality and temporal 
sequence. We had data only on mortality and no information 
on CLD or cancer incidence. The exposure measurement in 
our study was crude and, for some variables, not uniform as 
we pooled different surveys to obtain a sufficient number of 
deaths. Measurements were only assessed once at baseline 
precluding the consideration of, for example, smoking status 
over time. We had no information on objectively measur-
able mediators of the association between smoking/BMI and 
death.19,20 In fact, besides forced expiratory volume, resting 
heart rate, arm circumference, and other clinical parameters 
may blunt the impact of BMI on mortality when used in a 
joint model.19 The reliability of CLD on death certificates has 
been questioned.14 As a consequence, a dilution of the asso-
ciations might be expected. The close similarity of CLD and 
lung cancer mortality patterns in our study, however, does 
not support this concern. We did not consider that causes of 
death risk competition could vary depending on the length of 
follow-up time.21 Younger individuals (eg, aged ,40 years) 
did not notably contribute to CLD death. However, as any 
limitation of the age range would have been somewhat arbi-
trary, we decided to analyze the entire available age range.
In conclusion, underweight (for CLD and lung cancer) 
and obesity (for CLD only) were associated with an increased 
mortality risk independent of smoking status. Further 
research is required in order to evaluate the causality of 
this association and to identify the potential for prevention 
interventions. Our results stress the need to intensify smoking 
cessation efforts in people with low or high BMI and – even 
more importantly – to reinforce public health measures aimed 
at preventing smoking onset at an early stage of life.
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